Analysts expect Collegium Pharmaceutical, Inc to report revenue of 201.42 M for Q3 26, against a range of 190.15 M to 212.69 M. The most recent reported quarter, Q2 26, came in at 199.88 M, a 5.4% miss against the 211.18 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 159.30 M | 181.95 M | 177.76 M | 188.00 M | 209.36 M | 205.45 M | 193.52 M | 199.88 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 158.28 M | 202.58 M | 172.99 M | 182.36 M | 188.38 M | 213.79 M | 195.54 M | 225.63 M | 212.69 M | 252.31 M | 194.08 M | 246.67 M | 263.91 M | 237.21 M | 197.12 M | 205.38 M | ||||||||||
| Low Estimate | 136.51 M | 167.84 M | 147.40 M | 160.69 M | 176.41 M | 183.48 M | 163.78 M | 196.74 M | 190.15 M | 213.54 M | 182.64 M | 218.95 M | 220.34 M | 209.90 M | 166.46 M | 174.48 M | ||||||||||
| Consensus Estimate | 147.40 M | 185.21 M | 160.20 M | 171.52 M | 182.39 M | 198.63 M | 179.66 M | 211.18 M | 201.42 M | 232.92 M | 188.36 M | 232.81 M | 242.13 M | 223.56 M | 181.79 M | 189.93 M |
Analysts expect Collegium Pharmaceutical, Inc to report earnings per share of 1.95 for Q3 26, against a range of 1.77 to 2.13. The most recent reported quarter, Q2 26, came in at 1.92, a 8.5% beat against the 1.77 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.61 | 1.77 | 1.49 | 1.68 | 2.25 | 2.04 | 1.76 | 1.92 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.59 | 1.65 | 1.45 | 1.82 | 1.91 | 2.44 | 1.58 | 1.87 | 2.13 | 1.98 | 1.69 | 1.84 | 2.13 | 1.97 | 1.61 | 1.95 | ||||||||||
| Low Estimate | 1.49 | 1.51 | 1.25 | 1.60 | 1.59 | 2.04 | 1.30 | 1.67 | 1.77 | 1.74 | 1.57 | 1.68 | 1.79 | 1.81 | 1.51 | 1.81 | ||||||||||
| Consensus Estimate | 1.54 | 1.58 | 1.35 | 1.71 | 1.75 | 2.24 | 1.44 | 1.77 | 1.95 | 1.86 | 1.63 | 1.76 | 1.96 | 1.89 | 1.56 | 1.88 |
Pull Wall Street consensus for Collegium Pharmaceutical, Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=COLL&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "COLL", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=COLL&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();